Back to Top Skip to main content

BAMC, Argentine Army medical providers share COVID-19 best practices

Video teleconference image Argentine Army Col. Oscar Zarich, Argentine Partner Nation Liaison Officer, U.S. Army South, left, moderates a COVID-19 subject matter expert exchange between doctors from the Argentine Army and Brooke Army Medical Center, Oct. 21, 2020. The video teleconference consisted of a panel of medical professionals discussing lessons learned to provide a compilation of best practices in response to the COVID-19 pandemic and other health-related topics. (Photo by Robert A. Whetstone, Brooke Army Medical Center.)

Recommended Content:

Coronavirus | Global Health Engagement | Technology | COVID-19 Vaccine Efforts | Public Health | Convalescent Plasma Collection Program

Medical professionals from around the world are using technology to discuss COVID-19 best practices and share lessons learned. The Brooke Army Medical Center (BAMC) in San Antonio, Texas and Argentine Army’s Central Military Medical Hospital did not let 5,600 miles of separation keep them from discussing best practices against COVID-19.

U.S. Army South facilitated the virtual subject matter expert (SME) exchange between BAMC and CMMH, located in Buenos Aires, which touched on numerous topics and provided lessons learned for the participants. The exchange opened an avenue allowing doctors from both countries to discuss critical aspects of combating the disease to help protect the force and enhance readiness, while strengthening and building partnerships.

The exchange of best practices focused not only on readiness, but how to treat both COVID-19 and non-COVID-19 patients, staff protection, research and development, and testing protocols. A total of 17 medical practitioners participated in the virtual SME exchange.

Although they practice their craft in different countries, both teams understood the importance of reducing risk to staff as paramount to providing safe, quality care to service members and the local communities they serve.

At the beginning of the pandemic, BAMC started with a deliberate operations order to assess staff, logistics and bed expansion capacity. “We have many simultaneous missions to conduct,” said U.S. Army Col. Michael Wirt, BAMC deputy commanding officer. “Not just the mission to provide health care within our hospital; we also deploy some of our staff to respond to local, regional, and national requirements to support the COVID-19 crisis.”

In response to the pandemic, BAMC reduced its inpatient census, tightly managed personal protective equipment until the supply line became more predictable, limited the number of entrances to the hospital, conducted screening of everyone coming into the building, and began drive-through testing, in order to reduce the chance of infection in the hospital.

Both BAMC and CMMH treat COVID-19 and non-COVID-19 patients in separate areas. The CMMH team stated that COVID-19 areas follow strict protocols, requiring PPE in all entrance points. These specific wards are routinely disinfected and CMMH employs a security committee that ensures the non-COVID-19 area stays COVID-19-free.

Supply and demand, particularly with PPE and COVID-19 testing material, was a concern for both BAMC and CMMH. BAMC continues its partnership with University Health System and the Southwest Texas Regional Advisory Council to provide Level I Trauma care for 22 counties, encompassing 2.2 million people, even in the face of unprecedented healthcare system stress across the region. There are over 14 million people in the metropolitan area of Buenos Aires, and CMMH provides care to the military and general population. Even with PPE being such a prime commodity, CMMH manages to test their hospital staff of over 2,400 every 15 days, while still administering about 5,000 COVID-19 tests a day.

U.S. Air Force Col. Patrick Osborn, BAMC deputy commander for surgical services remarked on the trauma and emergency platform used to coordinate pandemic response with the local area and non-military medical healthcare systems. “That allowed for discussions on resources, testing, and policies on managing the pandemic, from a regional standpoint.”

The U.S. Air Force Secretarial Designee program allows BAMC to transport and accept extracorporeal membrane oxygenation (ECMO) patients for complex critical care when hospital capacity allows. The ECMO program provides significant community support for the sickest COVID-19 patients while furthering the readiness of numerous critical care personnel. 

“Through the infectious disease and public health communities, we have been working with public health in the state,” said U.S. Air Force Col. Heather Yun, BAMC deputy commander for medical services. “We’re one of many military health system hospitals in the United States, and all of our subject matter experts have been passing best practices back and forth and actually developing clinical practice guidelines. We’re on the sixth version [of the COVID-19 guidelines].”

Because of the fluid nature and constant learning surrounding COVID-19, protocols have been continuously changing for healthcare professionals. “We’ve had to write a lot of things in pencil, and rewrite them in pencil again two weeks later,” Yun explained. “We certainly follow CDC guidelines when it comes to things like infection prevention and control. When it comes to treatment protocols, we follow the science. Current protocols involve Dexamethasone and Remdesivir for hospitalized patients on oxygen.”

Practices and procedures that require high exposure is an obstacle that medical treatment facilities have to negotiate in order to maintain a safe environment during the pandemic.

When community transmission has been high, many non-emergency procedures are postponed until conditions are favorable. “We haven’t been doing a lot of elective surgeries or aerosol-generating procedures when we have a lot of community transmission,” said Yun. All patients are treated as a potential COVID-19 patient, guarding against the risk of transmission, she stated.

Communicating as a staff during the pandemic also offered challenges. CMMH and BAMC have had to rely on off-the-shelf technology to conduct meetings that would have otherwise been face-to-face.

BAMC is one of the participating sites of the clinical trials for Remdesivir as a treatment for COVID-19 infected patients. BAMC is also involved in trials with convalescent antibodies/convalescent plasma.

As part of the Operation Warp Speed goal to deliver safe and effective vaccines and therapeutics by January 2021, five DOD locations, to include BAMC, have been identified to participate in AstraZeneca’s the Phase III trial evaluating the vaccine candidate.  

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA IPM 18-017: Military Health System (MHS) Information Technology (IT) Investment Management Framework

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (v), establishes Defense Health Agency's (DHA) procedures to: .Establish the overarching guidance to implement policies and procedures for managing DHA Deputy Assistant Director, Information Operations (DAD IO)/J-6Defense Health Program (DHP) IT resources. The DHA Investment Management Framework is used as an enabler for MHS leadership to make informed transparent financial decisions associated with the DHA DAD IO/J-6 systems, services, and capabilities and will continue to be used in the foreseeable future.

  • Identification #: 18-017
  • Date: 11/7/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA IPM 18-015: Cybersecurity Program Management

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the requirements of References (d) through (y): • Establishes the Defense Health Agency’s (DHA) procedures to implement and maintain a DHA Cybersecurity Program for the Military Health System (MHS) to protect and defend DHA information and Information Technology (IT). • Is effective immediately; it will be converted into DHA-Procedural Instruction (DHA-PI), “Cybersecurity Program Management.” This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-015
  • Date: 10/28/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA IPM 18-007: Service Delivery Management Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (e): - Establishes the Defense Health Agency’s (DHA) procedures for implementing and managing high quality information technology (IT) services by the Chief Information Officer (CIO), Deputy Assistant Director Information Operations (DAD IO/J-6), Military Health System (MHS). The DHA Service Delivery Management program provides customers requesting IT services from the DAD IO/J-6 or Defense Information Systems Agency service catalogs with an on-demand, automated system that provides a single-entry point to submit service requests. The automated system enables DAD IO/J-6 to align business needs and use repeatable and scalable processes to holistically track, manage, and report on customer submitted requests for IT services from submission to fulfillment. - Is binding on DoD Components and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by the DHA. - This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction (DHA-PI). This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-007
  • Date: 7/28/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA IPM 18-016: DHA IPM 18 016 Medical Coding of the DoD Health Records

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (s): • Establishes the Defense Health Agency’s (DHA) procedures for centralized oversight, standardized operations, and ensured quality and performance for the coding of DoD Health Records. • This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire 12 months from the date of issue.

DHA IPM 18-011: Video Network Center (VNC) Endpoint Standards

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g): - Provides guidance for video network endpoint standards required for sites to connect to the Defense Health Agency (DHA) VNC network. These standards will help ensure security compliance, efficiency, and best practices are maintained across the DHA network. Meeting certification requirements brings many benefits, including: increased assurances of a successful video teleconference (VTC) experience, full access to bridge and point-to-point calls, and access to peer video networks, including the Department of Veterans Affairs, academia, and industry partners. Compliance with stated standards does not preclude users connecting to other DoD approved networks. - This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-011
  • Date: 9/20/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA IPM 18-013: Risk Management Framework (RMF)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (ac): • Incorporates cybersecurity strategy, policy, awareness/training, assessment, continuous monitoring, authorization, implementation, and remediation. • Aligns with the Deputy Assistant Director, Information Operations (DAD IO) J-6/Chief Information Officer’s (CIO) key concept of increasing cybersecurity of Defense Health Agency’s (DHA) Information Technology (IT); therefore, robust risk assessment and management is required. • Encompasses lifecycle risk management to determine and manage the residual cybersecurity risk. • This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-013
  • Date: 9/20/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA PI 3201.05: Technology Transfer (T2) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI) based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (t), establishes responsibilities, procedures, and guidance for the Defense Health Agency’s (DHA) T2 program.

  • Identification #: 3201.05
  • Date: 6/20/2019
  • Type: DHA Procedural Instruction
  • Topics: Technology
<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.